New recommendations to change the diagnostic criteria for Alzheimer's disease and recent advances in biomarker development may allow earlier diagnosis of this disease, potentially providing key tools for drug development.
This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Opar, A. Hope builds for earlier detection of Alzheimer's disease. Nat Rev Drug Discov 9, 579–581 (2010). https://doi.org/10.1038/nrd3237
Issue Date:
DOI: https://doi.org/10.1038/nrd3237
- Springer Nature Limited
This article is cited by
-
Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases
Nature Reviews Drug Discovery (2011)
-
Alzheimer's failure raises questions about disease-modifying strategies
Nature Reviews Drug Discovery (2010)